Vertebral Body Metastases¶
Definition¶
Vertebral body metastases are the most common malignant tumors of the spine. The vertebral bodies are the third most common site of skeletal metastases after the pelvis and ribs, and up to 70% of cancer patients develop spinal metastases during the course of their disease. The thoracic spine is most frequently affected, followed by the lumbar and cervical spine.
Primary Tumors¶
The most common primary cancers that metastasize to the spine (mnemonic: "BLT with a Kosher Pickle"):
- Breast
- Lung
- Thyroid
- Kidney (renal cell carcinoma)
- Prostate
Other common sources include melanoma, colorectal cancer, and hepatocellular carcinoma.
Pathophysiology¶
Metastases reach the spine via three routes:
- Hematogenous spread — The most common route, via the arterial system or Batson venous plexus (a valveless epidural venous plexus that communicates with pelvic veins, allowing direct venous spread from pelvic and abdominal tumors)
- Direct extension — From adjacent retroperitoneal or mediastinal tumors
- CSF seeding — Leptomeningeal (drop) metastases, discussed separately
Imaging Findings¶
MRI¶
MRI is the most sensitive modality for detecting vertebral metastases:
- T1-weighted — Low signal replacing normal bright fatty marrow, which can be focal or diffuse.
- T2-weighted — Usually high signal, though variable
- STIR — High signal; most sensitive for detection
- Post-contrast T1 with fat saturation — Enhancement of the metastatic deposits; essential for detecting epidural extension and cord compression
- DWI — Restricted diffusion in hypercellular metastatic deposits; useful for treatment response monitoring
Key features distinguishing metastatic from benign compression fractures:
- Convex posterior vertebral body contour (vs angular retropulsion in osteoporotic fractures)
- Pedicle involvement
- Epidural soft tissue mass
- Complete marrow replacement (vs band-like edema in benign fractures)
- Other vertebral lesions visible
CT¶
- Lytic bone destruction (most common pattern)
- Blastic (sclerotic) lesions — prostate, breast, carcinoid
- Mixed lytic-blastic — breast
- Pathological fracture with soft tissue mass
- Cortical destruction and pedicle erosion
Nuclear Medicine¶
- Bone scan — sensitive but nonspecific; detects osteoblastic response to metastatic disease
- PET/CT — more specific than bone scan; detects both lytic and blastic metastases; useful for treatment response assessment
Clinical Pearl
The "winking owl" sign on AP radiograph — absence of a pedicle shadow — is a classic early indicator of vertebral metastatic disease. On CT and MRI, pedicle involvement is one of the most reliable features distinguishing malignant from benign vertebral lesions. Always check the pedicles when evaluating a vertebral compression fracture.
Spinal Stability¶
The Spinal Instability Neoplastic Score (SINS) evaluates mechanical stability in patients with vertebral metastases, incorporating location, pain, bone lesion quality (lytic/blastic/mixed), alignment, vertebral body collapse, and posterolateral involvement.
Management¶
- Radiation therapy — Mainstay for pain control and local tumor control
- Surgery — For mechanical instability, progressive neurological deficit, or radiation-resistant tumors
- Systemic therapy — Chemotherapy, hormonal therapy, immunotherapy depending on tumor type
- Vertebral augmentation — Vertebroplasty/kyphoplasty for pathological fractures with intractable pain
Key Points¶
- Vertebral metastases are the most common malignant spinal tumors
- Breast, lung, thyroid, kidney, and prostate are the most common primary sites
- MRI with STIR and post-contrast sequences is the most sensitive imaging modality
- Pedicle involvement, convex posterior body contour, and epidural mass distinguish malignant from benign fractures
- The thoracic spine is most commonly affected
- Batson venous plexus provides a direct route for pelvic/abdominal tumor spread to the spine
References¶
- Gaillard F, et al. Vertebral metastases. Radiopaedia.org. Available at: https://radiopaedia.org/articles/vertebral-metastases. Accessed May 13, 2026.
- Shah LM, Salzman KL. Imaging of spinal metastatic disease. Int J Surg Oncol. 2011;2011:769753. doi:10.1155/2011/769753.
- Gottumukkala S, Srivastava U, Brocklehurst S, et al. Fundamentals of radiation oncology for treatment of vertebral metastases. RadioGraphics. 2021;41(7):2136-2156. doi:10.1148/rg.2021210052.
- Roberts CC, Daffner RH, Weissman BN, et al. ACR Appropriateness Criteria on metastatic bone disease. J Am Coll Radiol. 2010;7(6):400-409. doi:10.1016/j.jacr.2010.02.015.
- Fisher CG, DiPaola CP, Ryken TC, et al. A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group. Spine (Phila Pa 1976). 2010;35(22):E1221-E1229. doi:10.1097/BRS.0b013e3181e16ae2.
- Jung HS, Jee WH, McCauley TR, Ha KY, Choi KH. Discrimination of metastatic from acute osteoporotic compression spinal fractures with MR imaging. RadioGraphics. 2003;23(1):179-187. doi:10.1148/rg.231025043.
- Brook RC, Tung K, Oeppen R. Batson's plexus and retrograde venous spread of malignancy — a pictorial review. Cancer Imaging. 2014;14(Suppl 1):P40. doi:10.1186/1470-7330-14-S1-P40.